- News & Analysis
Page 780
Nabriva warms up for $92m IPO
Nabriva, a pneumonia treatment developer backed by Novartis, raised $120m in series B funding two months ago.
Jun 22, 2015Doctor On Demand treats $50m series B
Previously backed by Google, the telemedicine provider has now also added Qualcomm to its backers.
Jun 18, 2015CytomX triggers $70m series D
Fidelity has led the latest funding round for the Pfizer and Roche-backed antibody developer CytomX.
Jun 18, 2015Northwestern firm swipes $9.7m
Northwestern hand sanitizer startup SwipeSense secures $9.7m.
Jun 18, 2015Strem finds focus at Canberra
Strem Chemicals licenses out synthetic catalyst from Canberra which will boost efficiency in Ritalin manufacturing.
Jun 17, 2015About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin